Psychedelic Therapy In a Political Landscape: NIH Funding & Bipartisan Support w/ Dr. Carhart-Harris

Psychedelic Therapy In a Political Landscape: NIH Funding & Bipartisan Support w/ Dr. Carhart-Harris

In part one of my in-depth conversation with world-renowned neuroscientist Dr. Robin Carhart-Harris, we explore the political and cultural forces shaping the resurgence of psychedelic therapy.

We critique the dominant psychiatric paradigm, which has long reduced mental illness to purely neurochemical dysfunction (leading to the rise of SSRIs), ignoring the psychological, social, and spiritual roots of psychological suffering.

Carhart-Harris highlights how this narrow framework has failed to address rising rates of depression, PTSD, and OCD.

We also discuss the historical reluctance of institutions like the NIH to fund psychedelic research, despite mounting evidence of its therapeutic potential.

Under the previous leadership, psychedelic science was sidelined—but with new NIH leadership and a shifting political climate, there is fresh hope for meaningful support.

The conversation emphasizes the need for a more holistic, integrative approach to mental health—one that values inner healing, human agency, and the transformative power of psychedelic experiences.